|
⚲
|
| Keyboard |
| Guo-Liang Yu | |
|---|---|
| Firm | |
| Address | c/o Applied Stemcell, Inc 521 Cottonwood Drive 111 Milpitas, CA 95035 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Immune-Onc Therapeutics Inc | 021-271031 | Director | 7.0 M of 7.0 M |
||
| CB Therapeutics Inc | 021-268563 | Executive Officer | 4.0 M of 7.8 M |
||
| Applied Stemcell Inc | 021-265260 | Director | 19.0 M of 19.0 M |
||
| Quandx Inc | 021-252818 | Director | 3.0 M of 3.0 M |
||
| Siscapa Assay Technologies Inc | 021-215393 | Director | 1.0 M of 1.0 M |
||
| Nvigen Inc | 021-213842 | Director | 1.1 M of 1.5 M |
||
| Quandx Inc | 021-209964 | Director | 0.9 M of 1.5 M |
||
| Applied Stemcell Inc | 021-193949 | Director | 2.6 M of 3.6 M |
||
| Quandx Inc | 021-192587 | Director | 0.3 M of 0.4 M |
||
| Siscapa Assay Technologies Inc | 021-183157 | Director | 0.6 M of 1.6 M |
||
| Crown Bioscience Inc | 021-159173 | Executive Officer | 30.5 M of 32.2 M |
||
| Applied Stemcell Inc | 021-118995 | Director | 1.9 M of 2.5 M |
||